ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,032, issued on March 17, was assigned to Tris Pharma Inc. (Monmouth Junction, N.J.).
"Liquid clonidine extended release composition" was invented by Grishma Patel (East Brunswick, N.J.).
According to the abstract* released by the U.S. Patent & Trademark Office: "An oral clonidine dosage unit providing a twenty-four hour extended release profile following a single dose administration is provided. The dosage unit comprises a pharmaceutically effective amount of a coated complex comprising clonidine bound to a cationic exchange resin, which is characterized by a twenty-four hour release profile. Dosage units may also provide an immediate release component."
The patent was filed on...